Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Proto-oncogene c-Src (SRC) |
Target Info
|
Modulator |
[3] |
| Tyrosine-protein kinase ABL1 (ABL) |
Target Info
|
Modulator |
[3] |
| References |
Top |
| REF 1 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7731).
|
| REF 2 |
Current and future treatments of bone metastases. Expert Opin Emerg Drugs. 2008 Dec;13(4):609-27.
|
| REF 3 |
Novel dual Src/Abl inhibitors for hematologic and solid malignancies.Expert Opin Investig Drugs.2010 Aug;19(8):931-45.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
